logologo
QuantliQuantli

News

/

McCormick Stock Rises 1.6% on Earnings Beat and Strong Flavor Solutions Growth

NEWS

Market Mover

McCormick Stock Rises 1.6% on Earnings Beat and Strong Flavor Solutions Growth

Suhaib

Executive summary

McCormick reported Q2 earnings of $0.80 per share on revenue of $1.94 billion, beating analyst estimates and driving shares up 1.6%. The quarter was powered by strong Flavor Solutions performance and gross margin expansion of 270 basis points, even as U.S. consumer spices faced softer demand. Management reaffirmed full-year guidance and highlighted progress on the $44.8 billion Unilever Foods acquisition.

What happened

McCormick delivered Q2 results that exceeded Wall Street expectations, with earnings per share of $0.80 versus the consensus of $0.69 and revenue of $1.94 billion against an expected $1.9 billion. The Flavor Solutions segment led the way with 3% organic sales growth, driven equally by price and volume gains across CPG customers, private label, and branded foodservice. Gross margin expanded by 270 basis points, supported by productivity savings, the accretive impact of increased ownership in McCormick de Mexico, and a $28 million tariff refund that added roughly $0.07 to earnings. Management also advanced integration planning for the Unilever Foods deal, with over 200 people now dedicated to the effort and key milestones expected by September.

Why the stock moved

Shares climbed following the stronger-than-expected quarterly results and margin performance. The 15.9% earnings beat and 2% revenue surprise signaled that McCormick is managing cost pressures effectively while accelerating growth in its higher-margin Flavor Solutions business. Investors responded positively to gross margin expansion and the company's ability to reinvest tariff-related savings into brand marketing and innovation. Management's reaffirmation of full-year guidance and confidence in the Unilever integration timeline also reassured the market, despite ongoing weakness in U.S. consumer spices.

Bigger picture

McCormick is navigating a mixed demand environment where at-home cooking and health trends support category growth, but U.S. consumers remain price-sensitive in certain segments. The company is leaning into faster-growing categories like Mexican flavors, having launched 11 new Cholula products in May and completed a $750 million purchase of an additional 25% stake in McCormick de Mexico earlier this year. The pending Unilever acquisition remains a strategic priority, with management targeting mid- to high-single-digit adjusted EPS accretion in the first 12 months and operating margins of 23% to 25% by year three. However, the U.S. consumer business requires attention, and the company is refining pricing architecture and increasing value-focused marketing to restore volume growth by Q4.

What investors watch

The key question is whether McCormick can stabilize volume trends in U.S. consumer spices by the fourth quarter as planned. Management expects heavier spending on brand marketing, ERP systems, and incentive compensation to weigh on Q3 profit growth, which is projected in the high-single-digit to low-double-digit range. Investors will also monitor progress on the Unilever deal, with updates on the European secondary listing expected by end of July and detailed integration plans due by end of September. Inflation tracking toward the high end of mid-single-digit expectations and competitive pressure in the U.S. spice aisle remain near-term risks to watch.

#earnings
#company
#product

Comments (0)

MKC

McCormick & Company Inc

NYSE

•

Consumer Staples

$53.45

USD

+$0.54

(+1.02%)

At close: Jul 1, 2026, 4:00 PM EDT

Market Cap:

$14.41B

Volume:

4.4M

52w High:

$78.03

P/E Ratio:

18.25

View Company Page

Daily Analyst Ratings

Track how 1,000 Wall Street analysts rate stocks — updated daily.

See which S&P 500 stocks analysts expect to rise most.

View Top Upside Stocks

Top Gainers

SLBT

Horizon Space Acquisition II Corp

$5.99

+34.6%

PLBL

Polibeli Group Ltd

$10.26

+18.2%

GPC

Genuine Parts Co

$132.57

+12.9%

SLS

Sellas Life Sciences Group Inc

$14.98

+12.9%

View all

Upcoming IPOs